Global Neuroprotection Market by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 129 pages | ID: GA3BD49F326EN
GlobalInfoResearch

Abstracts

Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases.

Scope of the Report:

This report studies the Neuroprotection market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuroprotection market by product type and applications/end industries.

The global Neuroprotection market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuroprotection.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• F. Hoffmann-La Roche
• Eli Lilly and Company
• Daiichi Sankyo Company
• Allergan
• Novartis
• AstraZeneca
• Dr. Reddy's Laboratories
• Astrocyte Pharmaceuticals
• Teva Pharmaceutical Industries
• Biogen

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Free Anti-Inflammatory Agents
• Radical Trapping Agents (Antioxidants)
• Apoptosis Inhibitors
• Glutamate Antagonists (Anti-Excitotoxic Agents)
• Neurotrophic Factors (NTFs)
• Stimulants
• Metal Ion Chelators
• Other Products

Market Segment by Applications, can be divided into

• Prevention
• Treatment

Contents

1 NEUROPROTECTION MARKET OVERVIEW

1.1 Product Overview and Scope of Neuroprotection
1.2 Classification of Neuroprotection by Types
  1.2.1 Global Neuroprotection Revenue Comparison by Types (2017-2023)
  1.2.2 Global Neuroprotection Revenue Market Share by Types in 2017
  1.2.3 Free Anti-Inflammatory Agents
  1.2.4 Radical Trapping Agents (Antioxidants)
  1.2.5 Apoptosis Inhibitors
  1.2.6 Glutamate Antagonists (Anti-Excitotoxic Agents)
  1.2.7 Neurotrophic Factors (NTFs)
  1.2.8 Stimulants
  1.2.9 Metal Ion Chelators
  1.2.10 Other Products
1.3 Global Neuroprotection Market by Application
  1.3.1 Global Neuroprotection Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Prevention
  1.3.3 Treatment
1.4 Global Neuroprotection Market by Regions
  1.4.1 Global Neuroprotection Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Neuroprotection Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroprotection Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroprotection Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Neuroprotection Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroprotection Status and Prospect (2013-2023)
1.5 Global Market Size of Neuroprotection (2013-2023)

2 MANUFACTURERS PROFILES

2.1 F. Hoffmann-La Roche
  2.1.1 Business Overview
  2.1.2 Neuroprotection Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 F. Hoffmann-La Roche Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly and Company
  2.2.1 Business Overview
  2.2.2 Neuroprotection Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Eli Lilly and Company Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.3 Daiichi Sankyo Company
  2.3.1 Business Overview
  2.3.2 Neuroprotection Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Daiichi Sankyo Company Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan
  2.4.1 Business Overview
  2.4.2 Neuroprotection Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Allergan Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
  2.5.1 Business Overview
  2.5.2 Neuroprotection Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Novartis Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
  2.6.1 Business Overview
  2.6.2 Neuroprotection Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 AstraZeneca Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.7 Dr. Reddy's Laboratories
  2.7.1 Business Overview
  2.7.2 Neuroprotection Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Dr. Reddy's Laboratories Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.8 Astrocyte Pharmaceuticals
  2.8.1 Business Overview
  2.8.2 Neuroprotection Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Astrocyte Pharmaceuticals Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical Industries
  2.9.1 Business Overview
  2.9.2 Neuroprotection Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Teva Pharmaceutical Industries Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
2.10 Biogen
  2.10.1 Business Overview
  2.10.2 Neuroprotection Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Biogen Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL NEUROPROTECTION MARKET COMPETITION, BY PLAYERS

3.1 Global Neuroprotection Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Neuroprotection Players Market Share
  3.2.2 Top 10 Neuroprotection Players Market Share
3.3 Market Competition Trend

4 GLOBAL NEUROPROTECTION MARKET SIZE BY REGIONS

4.1 Global Neuroprotection Revenue and Market Share by Regions
4.2 North America Neuroprotection Revenue and Growth Rate (2013-2018)
4.3 Europe Neuroprotection Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neuroprotection Revenue and Growth Rate (2013-2018)
4.5 South America Neuroprotection Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neuroprotection Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA NEUROPROTECTION REVENUE BY COUNTRIES

5.1 North America Neuroprotection Revenue by Countries (2013-2018)
5.2 USA Neuroprotection Revenue and Growth Rate (2013-2018)
5.3 Canada Neuroprotection Revenue and Growth Rate (2013-2018)
5.4 Mexico Neuroprotection Revenue and Growth Rate (2013-2018)

6 EUROPE NEUROPROTECTION REVENUE BY COUNTRIES

6.1 Europe Neuroprotection Revenue by Countries (2013-2018)
6.2 Germany Neuroprotection Revenue and Growth Rate (2013-2018)
6.3 UK Neuroprotection Revenue and Growth Rate (2013-2018)
6.4 France Neuroprotection Revenue and Growth Rate (2013-2018)
6.5 Russia Neuroprotection Revenue and Growth Rate (2013-2018)
6.6 Italy Neuroprotection Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC NEUROPROTECTION REVENUE BY COUNTRIES

7.1 Asia-Pacific Neuroprotection Revenue by Countries (2013-2018)
7.2 China Neuroprotection Revenue and Growth Rate (2013-2018)
7.3 Japan Neuroprotection Revenue and Growth Rate (2013-2018)
7.4 Korea Neuroprotection Revenue and Growth Rate (2013-2018)
7.5 India Neuroprotection Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neuroprotection Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA NEUROPROTECTION REVENUE BY COUNTRIES

8.1 South America Neuroprotection Revenue by Countries (2013-2018)
8.2 Brazil Neuroprotection Revenue and Growth Rate (2013-2018)
8.3 Argentina Neuroprotection Revenue and Growth Rate (2013-2018)
8.4 Colombia Neuroprotection Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE NEUROPROTECTION BY COUNTRIES

9.1 Middle East and Africa Neuroprotection Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neuroprotection Revenue and Growth Rate (2013-2018)
9.3 UAE Neuroprotection Revenue and Growth Rate (2013-2018)
9.4 Egypt Neuroprotection Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neuroprotection Revenue and Growth Rate (2013-2018)
9.6 South Africa Neuroprotection Revenue and Growth Rate (2013-2018)

10 GLOBAL NEUROPROTECTION MARKET SEGMENT BY TYPE

10.1 Global Neuroprotection Revenue and Market Share by Type (2013-2018)
10.2 Global Neuroprotection Market Forecast by Type (2018-2023)
10.3 Free Anti-Inflammatory Agents Revenue Growth Rate (2013-2023)
10.4 Radical Trapping Agents (Antioxidants) Revenue Growth Rate (2013-2023)
10.5 Apoptosis Inhibitors Revenue Growth Rate (2013-2023)
10.6 Glutamate Antagonists (Anti-Excitotoxic Agents) Revenue Growth Rate (2013-2023)
10.7 Neurotrophic Factors (NTFs) Revenue Growth Rate (2013-2023)
10.8 Stimulants Revenue Growth Rate (2013-2023)
10.9 Metal Ion Chelators Revenue Growth Rate (2013-2023)
10.10 Other Products Revenue Growth Rate (2013-2023)

11 GLOBAL NEUROPROTECTION MARKET SEGMENT BY APPLICATION

11.1 Global Neuroprotection Revenue Market Share by Application (2013-2018)
11.2 Neuroprotection Market Forecast by Application (2018-2023)
11.3 Prevention Revenue Growth (2013-2018)
11.4 Treatment Revenue Growth (2013-2018)

12 GLOBAL NEUROPROTECTION MARKET SIZE FORECAST (2018-2023)

12.1 Global Neuroprotection Market Size Forecast (2018-2023)
12.2 Global Neuroprotection Market Forecast by Regions (2018-2023)
12.3 North America Neuroprotection Revenue Market Forecast (2018-2023)
12.4 Europe Neuroprotection Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neuroprotection Revenue Market Forecast (2018-2023)
12.6 South America Neuroprotection Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neuroprotection Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neuroprotection Picture
Table Product Specifications of Neuroprotection
Table Global Neuroprotection and Revenue (Million USD) Market Split by Product Type
Figure Global Neuroprotection Revenue Market Share by Types in 2017
Figure Free Anti-Inflammatory Agents Picture
Figure Radical Trapping Agents (Antioxidants) Picture
Figure Apoptosis Inhibitors Picture
Figure Glutamate Antagonists (Anti-Excitotoxic Agents) Picture
Figure Neurotrophic Factors (NTFs) Picture
Figure Stimulants Picture
Figure Metal Ion Chelators Picture
Figure Other Products Picture
Table Global Neuroprotection Revenue (Million USD) by Application (2013-2023)
Figure Neuroprotection Revenue Market Share by Applications in 2017
Figure Prevention Picture
Figure Treatment Picture
Table Global Market Neuroprotection Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Neuroprotection Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Neuroprotection Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Neuroprotection Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Neuroprotection Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Neuroprotection Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Neuroprotection Revenue (Million USD) and Growth Rate (2013-2023)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Neuroprotection Type and Applications
Table F. Hoffmann-La Roche Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Neuroprotection Type and Applications
Table Eli Lilly and Company Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Company Neuroprotection Type and Applications
Table Daiichi Sankyo Company Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Neuroprotection Type and Applications
Table Allergan Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Neuroprotection Type and Applications
Table Novartis Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Neuroprotection Type and Applications
Table AstraZeneca Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Neuroprotection Type and Applications
Table Dr. Reddy's Laboratories Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Astrocyte Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Astrocyte Pharmaceuticals Neuroprotection Type and Applications
Table Astrocyte Pharmaceuticals Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Neuroprotection Type and Applications
Table Teva Pharmaceutical Industries Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Neuroprotection Type and Applications
Table Biogen Neuroprotection Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neuroprotection Revenue (Million USD) by Players (2013-2018)
Table Global Neuroprotection Revenue Share by Players (2013-2018)
Figure Global Neuroprotection Revenue Share by Players in 2016
Figure Global Neuroprotection Revenue Share by Players in 2017
Figure Global Top 5 Players Neuroprotection Revenue Market Share in 2017
Figure Global Top 10 Players Neuroprotection Revenue Market Share in 2017
Figure Global Neuroprotection Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Neuroprotection Revenue (Million USD) by Regions (2013-2018)
Table Global Neuroprotection Revenue Market Share by Regions (2013-2018)
Figure Global Neuroprotection Revenue Market Share by Regions (2013-2018)
Figure Global Neuroprotection Revenue Market Share by Regions in 2017
Figure North America Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Europe Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Neuroprotection Revenue and Growth Rate (2013-2018)
Figure South America Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Neuroprotection Revenue and Growth Rate (2013-2018)
Table North America Neuroprotection Revenue by Countries (2013-2018)
Table North America Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure North America Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure North America Neuroprotection Revenue Market Share by Countries in 2017
Figure USA Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Canada Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Mexico Neuroprotection Revenue and Growth Rate (2013-2018)
Table Europe Neuroprotection Revenue (Million USD) by Countries (2013-2018)
Figure Europe Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Europe Neuroprotection Revenue Market Share by Countries in 2017
Figure Germany Neuroprotection Revenue and Growth Rate (2013-2018)
Figure UK Neuroprotection Revenue and Growth Rate (2013-2018)
Figure France Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Russia Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Italy Neuroprotection Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neuroprotection Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Neuroprotection Revenue Market Share by Countries in 2017
Figure China Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Japan Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Korea Neuroprotection Revenue and Growth Rate (2013-2018)
Figure India Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Neuroprotection Revenue and Growth Rate (2013-2018)
Table South America Neuroprotection Revenue by Countries (2013-2018)
Table South America Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure South America Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure South America Neuroprotection Revenue Market Share by Countries in 2017
Figure Brazil Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Argentina Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Colombia Neuroprotection Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neuroprotection Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neuroprotection Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neuroprotection Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neuroprotection Revenue and Growth Rate (2013-2018)
Figure UAE Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Egypt Neuroprotection Revenue and Growth Rate (2013-2018)
Figure Nigeria Neuroprotection Revenue and Growth Rate (2013-2018)
Figure South Africa Neuroprotection Revenue and Growth Rate (2013-2018)
Table Global Neuroprotection Revenue (Million USD) by Type (2013-2018)
Table Global Neuroprotection Revenue Share by Type (2013-2018)
Figure Global Neuroprotection Revenue Share by Type (2013-2018)
Figure Global Neuroprotection Revenue Share by Type in 2017
Table Global Neuroprotection Revenue Forecast by Type (2018-2023)
Figure Global Neuroprotection Market Share Forecast by Type (2018-2023)
Figure Global Free Anti-Inflammatory Agents Revenue Growth Rate (2013-2018)
Figure Global Radical Trapping Agents (Antioxidants) Revenue Growth Rate (2013-2018)
Figure Global Apoptosis Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Glutamate Antagonists (Anti-Excitotoxic Agents) Revenue Growth Rate (2013-2018)
Figure Global Neurotrophic Factors (NTFs) Revenue Growth Rate (2013-2018)
Figure Global Stimulants Revenue Growth Rate (2013-2018)
Figure Global Metal Ion Chelators Revenue Growth Rate (2013-2018)
Figure Global Other Products Revenue Growth Rate (2013-2018)
Table Global Neuroprotection Revenue by Application (2013-2018)
Table Global Neuroprotection Revenue Share by Application (2013-2018)
Figure Global Neuroprotection Revenue Share by Application (2013-2018)
Figure Global Neuroprotection Revenue Share by Application in 2017
Table Global Neuroprotection Revenue Forecast by Application (2018-2023)
Figure Global Neuroprotection Market Share Forecast by Application (2018-2023)
Figure Global Prevention Revenue Growth Rate (2013-2018)
Figure Global Treatment Revenue Growth Rate (2013-2018)
Figure Global Neuroprotection Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Neuroprotection Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Neuroprotection Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Neuroprotection Revenue Market Forecast (2018-2023)
Figure Europe Neuroprotection Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Neuroprotection Revenue Market Forecast (2018-2023)
Figure South America Neuroprotection Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Neuroprotection Revenue Market Forecast (2018-2023)